La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.

Identifieur interne : 000D99 ( Main/Merge ); précédent : 000D98; suivant : 000E00

Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.

Auteurs : R. Abdalian [Canada] ; O. Saqui ; G. Fernandes ; J P Allard

Source :

RBID : pubmed:22829428

Descripteurs français

English descriptors

Abstract

Long-term parenteral nutrition (PN) can be associated with micronutrient deficiency or toxicity depending on supplementation. Recently, hypermanganesemia and potential neurological toxicity were reported. The aim of this study was to assess the effect of manganese supplementation in a sample of patients on long-term PN receiving manganese (Mn) as part of a multi-trace element (TE) supplement.

DOI: 10.1177/0148607112454543
PubMed: 22829428

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22829428

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.</title>
<author>
<name sortKey="Abdalian, R" sort="Abdalian, R" uniqKey="Abdalian R" first="R" last="Abdalian">R. Abdalian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Internal Medicine, Gastroenterology & Clinical Nutrition, North York General Hospital, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Internal Medicine, Gastroenterology & Clinical Nutrition, North York General Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Saqui, O" sort="Saqui, O" uniqKey="Saqui O" first="O" last="Saqui">O. Saqui</name>
</author>
<author>
<name sortKey="Fernandes, G" sort="Fernandes, G" uniqKey="Fernandes G" first="G" last="Fernandes">G. Fernandes</name>
</author>
<author>
<name sortKey="Allard, J P" sort="Allard, J P" uniqKey="Allard J" first="J P" last="Allard">J P Allard</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:22829428</idno>
<idno type="pmid">22829428</idno>
<idno type="doi">10.1177/0148607112454543</idno>
<idno type="wicri:Area/PubMed/Corpus">000898</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000898</idno>
<idno type="wicri:Area/PubMed/Curation">000898</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000898</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000898</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000898</idno>
<idno type="wicri:Area/Ncbi/Merge">001207</idno>
<idno type="wicri:Area/Ncbi/Curation">001207</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001207</idno>
<idno type="wicri:doubleKey">0148-6071:2013:Abdalian R:effects:of:manganese</idno>
<idno type="wicri:Area/Main/Merge">000D99</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.</title>
<author>
<name sortKey="Abdalian, R" sort="Abdalian, R" uniqKey="Abdalian R" first="R" last="Abdalian">R. Abdalian</name>
<affiliation wicri:level="1">
<nlm:affiliation>Internal Medicine, Gastroenterology & Clinical Nutrition, North York General Hospital, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Internal Medicine, Gastroenterology & Clinical Nutrition, North York General Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Saqui, O" sort="Saqui, O" uniqKey="Saqui O" first="O" last="Saqui">O. Saqui</name>
</author>
<author>
<name sortKey="Fernandes, G" sort="Fernandes, G" uniqKey="Fernandes G" first="G" last="Fernandes">G. Fernandes</name>
</author>
<author>
<name sortKey="Allard, J P" sort="Allard, J P" uniqKey="Allard J" first="J P" last="Allard">J P Allard</name>
</author>
</analytic>
<series>
<title level="j">JPEN. Journal of parenteral and enteral nutrition</title>
<idno type="ISSN">0148-6071</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Attention (drug effects)</term>
<term>Brain (drug effects)</term>
<term>Brain (pathology)</term>
<term>Canada (epidemiology)</term>
<term>Cognition Disorders (blood)</term>
<term>Cognition Disorders (chemically induced)</term>
<term>Cognition Disorders (epidemiology)</term>
<term>Depression (blood)</term>
<term>Depression (chemically induced)</term>
<term>Depression (epidemiology)</term>
<term>Dietary Supplements (adverse effects)</term>
<term>Female</term>
<term>Gait (drug effects)</term>
<term>Gait Disorders, Neurologic (blood)</term>
<term>Gait Disorders, Neurologic (chemically induced)</term>
<term>Gait Disorders, Neurologic (epidemiology)</term>
<term>Humans</term>
<term>Male</term>
<term>Manganese (adverse effects)</term>
<term>Manganese (blood)</term>
<term>Memory Disorders (blood)</term>
<term>Memory Disorders (chemically induced)</term>
<term>Memory Disorders (epidemiology)</term>
<term>Middle Aged</term>
<term>Parenteral Nutrition</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (etiology)</term>
<term>Trace Elements (adverse effects)</term>
<term>Trace Elements (blood)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Manganese</term>
<term>Trace Elements</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Manganese</term>
<term>Trace Elements</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Dietary Supplements</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Cognition Disorders</term>
<term>Depression</term>
<term>Gait Disorders, Neurologic</term>
<term>Memory Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Cognition Disorders</term>
<term>Depression</term>
<term>Gait Disorders, Neurologic</term>
<term>Memory Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Attention</term>
<term>Brain</term>
<term>Gait</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Cognition Disorders</term>
<term>Depression</term>
<term>Gait Disorders, Neurologic</term>
<term>Memory Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parenteral Nutrition</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Long-term parenteral nutrition (PN) can be associated with micronutrient deficiency or toxicity depending on supplementation. Recently, hypermanganesemia and potential neurological toxicity were reported. The aim of this study was to assess the effect of manganese supplementation in a sample of patients on long-term PN receiving manganese (Mn) as part of a multi-trace element (TE) supplement.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D99 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000D99 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:22829428
   |texte=   Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:22829428" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022